Companies now sell polygenic embryo selection that claims to lower disease risk and slightly raise IQ. Most traits are controlled by thousands of genes and current scores mix real effects with population confounders, so they work poorly within families and picking the best of a few embryos gives only small benefits. Critics warn of scientific limits, ethical problems, and social risks if screening and IVF become widespread.
-
How did X-Rays gain mass adoption? #
, 3 highlightsWilhelm Röntgen took the first X-Ray (XR) and presented his work “On a New Kind of Rays” in December 1895 which was printed in January 1986. ... There were 49 monographs and 1044 research papers on XRs in 1896 alone.
when Roentgen discovered XRs there was no federal device regulation in place. The first law to touch devices was in 1938. Today, we have heavy pre-market regulation. This regulatory oversight itself has many pros (protecting patients, exceeding standard of care) but also its faults (limiting pace of new technology).
XRs would not have taken off if patients and the public did not want to pay for it. In fact, hospitals charged $1-3 per image that were billed directly to the patient in a fee-for-service model. Self-pay made up about 70-80% of hospital payments, charity represented 5-10%, and the remaining was from state or municipal lump sum payments for patients who could not afford to pay.
-
Endometriosis is an incredibly interesting disease #
, 1 highlightit is when tissue that resembles the uterine lining, or endometrial-like tissue, grows outside the uterus. The tissue can implant itself in nearby tissues, like the ovaries and fallopian tubes, or even more distal organs like the bladder and bowel. Due to the continuous influx of hormonal growth factors (mainly estrogen), these misplaced endometrial-like cells respond cyclically, just as the normal uterine lining does. They thicken, break down, and bleed with each menstrual cycle, but unlike the uterine lining, they have nowhere to go.